GlassScriptPhysician profile
Taylor J Jackson
NPI 1326543752
$4,890.54
in general payments reported to CMS, 2019-2025
8 companies · $1,277 in 2025
The $1,277 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $926 · 2020: $90.18 · 2021: $107 · 2022: $398 · 2023: $742 · 2024: $1,352 · 2025: $1,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,874 · Travel and Lodging: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,873.86 |
| Travel and Lodging | $496.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,883.74 | 2021-2025 | Unid_pass, Cd Horizon Spinal System, Stealthstation S8 Platform |
| Stryker Corporation | $1,749.49 | 2019-2024 | Gamma, N/A, Axsos |
| Globus Medical, INC. | $496.62 | 2025 | Acp |
| Alphatec Spine, INC | $224.49 | 2024 | |
| Zimvie INC. | $190.89 | 2023 | |
| Cerapedics INC. | $132.92 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $122.21 | 2023 | Na |
| Si-Bone, INC. | $90.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.